Med Life S.A. (BVB:M)

Romania flag Romania · Delayed Price · Currency is RON
12.22
-0.48 (-3.78%)
At close: Apr 28, 2026
Market Cap6.49B +91.2%
Revenue (ttm)3.17B +16.9%
Net Income11.27M -55.0%
EPS0.02 -55.3%
Shares Out530.82M
PE Ratio575.71
Forward PE55.55
Dividendn/a
Ex-Dividend Daten/a
Volume173,006
Average Volume106,151
Open12.70
Previous Close12.70
Day's Range12.10 - 13.08
52-Week Range5.73 - 14.46
Beta0.57
RSI50.41
Earnings DateMar 30, 2026

About Med Life

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecul... [Read more]

Industry Health Services
Founded 1996
Employees 6,962
Stock Exchange Bucharest Stock Exchange
Ticker Symbol M
Full Company Profile

Financial Performance

In 2025, Med Life's revenue was 3.17 billion, an increase of 16.86% compared to the previous year's 2.72 billion. Earnings were 11.27 million, a decrease of -55.00%.

Financial Statements

News

Med Life Earnings Call Transcript: Q3 2025

Turnover grew 19.5% to RON 2.36 billion in the first nine months, with hospitals and clinics leading growth. EBITDA rose 20.4%, but net profit dropped 88% due to FX losses. Investments focused on new facilities, AI, and genetic testing, while debt and CapEx were closely managed.

5 months ago - Transcripts

Med Life Earnings Call Transcript: Q2 2025

Turnover grew 20% to RON 1.57 billion in H1 2025, with 16% organic growth and strong EBITDA margin. Major acquisitions, tech investments, and new hospital units drove expansion, while FX losses and fiscal changes weighed on net results.

8 months ago - Transcripts

Med Life Earnings Call Transcript: Q4 2024

2024 saw 25% revenue growth and a 43% rise in EBITDA, driven by organic expansion and five acquisitions. Margin and net debt/EBITDA improved, with new hospitals and digital services launched. 2025 will focus on completing ongoing projects and prudent M&A.

1 year ago - Transcripts